IMARC Group, a leading market research company, has recently released a report titled “Hospital Infection Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028.” The study provides a detailed analysis of the industry, including the global hospital infection therapeutics market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How Big is the Hospital Infection Therapeutics Market?

The global hospital infection therapeutics market size reached US$ 11.8 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 15.8 Billion by 2028, exhibiting a growth rate (CAGR) of 4.8% during 2023-2028.

What is Hospital Infection Therapeutics?

Hospital infection therapeutics, also known as healthcare-associated infection (HAI) therapeutics, encompasses a vital segment within the healthcare industry dedicated to combating infections that patients acquire while receiving medical treatment or care within healthcare facilities. These infections, often referred to as nosocomial infections, can occur during hospital stays, outpatient procedures, or in other healthcare settings. Hospital infection therapeutics focuses on the diagnosis, prevention, and treatment of these infections, which can range from surgical site infections to bloodstream infections, respiratory infections, and urinary tract infections. The prevention and management of HAIs are critical to ensuring patient safety, reducing healthcare costs, and maintaining the overall quality of healthcare services.

Request For a PDF Sample Report: https://www.imarcgroup.com/hospital-infection-therapeutics-market/requestsample

What are the Growth Prospects and Trends in the Hospital Infection Therapeutics Industry?

The global hospital infection therapeutics market is primarily being driven by the rise in antimicrobial resistance. As bacteria and other pathogens develop resistance to commonly used antibiotics, the need for innovative therapeutics becomes more pronounced. The emergence of multidrug-resistant organisms, often associated with HAIs, has heightened the demand for effective treatment options. Moreover, stringent infection control regulations and guidelines play a pivotal role in shaping the market. Healthcare regulatory bodies worldwide have implemented strict standards and protocols to prevent and manage HAIs. Compliance with these guidelines drives the adoption of infection control products and therapeutics, particularly in healthcare facilities aiming to minimize the risk of infections.

In addition to this, the COVID-19 pandemic has further emphasized the importance of infection control and therapeutics. Hospitals and healthcare institutions have intensified their focus on infection prevention and management, leading to increased demand for HAI therapeutics. The pandemic has underscored the critical need for robust infection control measures, and this awareness is expected to persist beyond the immediate response to the virus. This is creating a positive outlook for the market further across the globe.

Who are the Key Players Operating in the Hospital Infection Therapeutics Market?

The report has also analysed the competitive landscape of the market with some of the key players.

• Allergan Plc (AbbVie Inc.)
• AstraZeneca Plc
• Bayer Aktiengesellschaft
• Bristol-Myers Squibb Company
• Hoffmann-La Roche AG (Roche Holding AG)
• Gilead Sciences Inc.
• GlaxoSmithKline plc
• Johnson Johnson
• Merck Co. Inc
• Pfizer Inc.
• Sanofi S.A.

What is Included in Market Segmentation?

The report has categorized the market based on drug type and indication.

Breakup by Drug Type:

• Anti-bacterial Drugs
• Anti-fungal Drugs
• Anti-viral Drugs
• Others

Breakup by Indication:

• Blood Stream Infections
• Urinary Tract Infections
• Surgical Site Infections
• Pneumonia
• Others

Regional Analysis:

• North America
• Europe
• Asia Pacific 
• Latin America
• Middle East and Africa

Ask Analyst for Customization and Explore full report with TOC List of Figures: https://www.imarcgroup.com/request?type=reportid=2393flag=C

Key Highlights of The Report:   

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:

Company Name: IMARC Group
Contact Person: Elena Anderson
Email: [email protected]
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com